Related Experiment Video
Updated: Jun 12, 2026

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae
Published on: February 25, 2022
RNA Structural Biology of Neurodegeneration: Phase Separation, Phase Transition, and Proteinopathy
Yasushi Yabuki1,2, Norifumi Shioda1,2
1Department of Genomic Neurology, Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-0811, Japan.
None:
Neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease, are becoming increasingly prevalent in super-aging societies. However, the molecular mechanisms by which prion-like proteins undergo aberrant phase transition, aggregation, and propagation during neurodegeneration remain incompletely understood. Although these proteins are capable of undergoing liquid-liquid phase separation (LLPS) followed by a sol-gel transition in vitro, the factors that govern their pathological phase transition in vivo remain largely elusive. Notably, many prion-like proteins also possess RNA-binding properties, and accumulating evidence indicates that RNA plays pivotal roles in regulating both LLPS and the subsequent transition to more solid-like states. In this review, we summarize recent advances in the RNA structural biology of neurodegeneration, with particular emphasis on RNA G-quadruplexes (rG4s) as pathological determinants, and discuss emerging mechanisms by which RNA structures promote the phase transition and proteinopathy of prion-like proteins.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Parkinson Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
